Results for tag: "Wiskott Aldrich Syndrome Drug"

The Wiskott Aldrich Syndrome Drug market is a subset of the larger Immune Disorders Drugs market. It is a rare, X-linked recessive disorder that affects the immune system, leading to increased susceptibility to infections, eczema, and thrombocytopenia. Treatment for Wiskott Aldrich Syndrome includes immunosuppressive drugs, bone marrow transplantation, and gene therapy. The Wiskott Aldrich Syndrome Drug market is composed of a variety of companies that specialize in the development and manufacture of drugs to treat the disorder. These companies include Novartis, Pfizer, Shire, and Alexion Pharmaceuticals. Additionally, there are a number of smaller companies that are involved in the development of new treatments for Wiskott Aldrich Syndrome. Show Less Read more